Percutaneous Coronary Interventions Using a Ridaforolimus‐Eluting Stent in Patients at High Bleeding Risk

Background Patients treated with percutaneous coronary intervention are often considered to be at a high bleeding risk (HBR). Drug‐eluting stents have been shown to be superior to bare‐metal stents in patients with HBR, even when patients were given abbreviated periods of dual antiplatelet therapy (...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ran Kornowski, Maayan Konigstein, Michael Jonas, Abid Assali, Hana Vaknin‐Assa, Amit Segev, Haim Danenberg, Majdi Halabi, Ariel Roguin, Arthur Kerner, Eli Lev, Grigoris V. Karamasis, Thomas W. Johnson, Richard Anderson, Jonathan Blaxill, Sachin Jadhav, Stephen Hoole, Guy Witberg, Melek Ozgu Issever, Ori Ben‐Yehuda, Andreas Baumbach
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-01-01
coleção:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Assuntos:	antithrombotic therapy coronary artery disease high bleeding risk percutaneous coronary intervention
Acesso em linha:	https://www.ahajournals.org/doi/10.1161/JAHA.122.029051
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!